European Journal of Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
185, P. 106427 - 106427
Published: March 21, 2023
Prostate
cancer
remains
a
serious
condition
threatening
the
health
of
men.
Due
to
complicated
nature
tumour
microenvironment
(TME),
conventional
treatments
face
challenges
including
poor
prognosis
and
resistance,
therefore
new
therapeutic
strategies
are
urgently
needed.
Small
interfering
RNA
(siRNA),
double-stranded
non-coding
RNA,
regulates
specific
gene
expression
through
interference.
Tumour-associated
macrophages
(TAMs)
potential
target
in
immunotherapy.
Colony
stimulating
factor-1/colony
factor-1
receptor
(CSF-1/CSF-1R)
signaling
pathway
plays
crucial
role
polarization
immunosuppressive
TAMs,
M2
macrophages.
Downregulation
CSF-1R
is
known
reprogram
macrophages,
immunostimulatory
phenotype,
M1
Sialic
acid
ligand
for
Siglec-1
(CD169)
which
overexpressed
on
with
little
other
phenotypes.
Therefore,
sialic
acid-targeted
cyclodextrin-based
nanoparticle
was
developed
specifically
deliver
siRNA
The
nanoparticles
were
studied
vitro
using
both
human
mouse
prostate
cell
lines.
Results
show
that
targeted
achieved
delivery
via
acid-CD169
axis.
significantly
downregulated
(29.64%
vs
19.31%
non-targeted
THP-1-derived
38.94%
18.51%
RAW
264.7-derived
n
=
4,
p
<
0.01).
resulting
reprograming
enhanced
level
apoptosis
cells
Transwell
model
(49.17%
37.68%
PC-3
69.15%
44.73%
TRAMP
C1
cells,
3,
Thus,
this
drug
system
provides
strategy
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 1, 2024
Abstract
Combining
existing
drug
therapy
is
essential
in
developing
new
therapeutic
agents
disease
prevention
and
treatment.
In
preclinical
investigations,
combined
effect
of
certain
known
drugs
has
been
well
established
treating
extensive
human
diseases.
Attributed
to
synergistic
effects
by
targeting
various
pathways
advantages,
such
as
reduced
administration
dose,
decreased
toxicity,
alleviated
resistance,
combinatorial
treatment
now
being
pursued
delivering
combat
major
clinical
illnesses,
cancer,
atherosclerosis,
pulmonary
hypertension,
myocarditis,
rheumatoid
arthritis,
inflammatory
bowel
disease,
metabolic
disorders
neurodegenerative
Combinatorial
involves
combining
or
co-delivering
two
more
for
a
specific
disease.
Nanoparticle
(NP)-mediated
delivery
systems,
i.e.,
liposomal
NPs,
polymeric
NPs
nanocrystals,
are
great
interest
wide
range
due
targeted
delivery,
extended
release,
higher
stability
avoid
rapid
clearance
at
infected
areas.
This
review
summarizes
targets
diseases,
clinically
approved
combinations
the
development
multifunctional
emphasizes
strategies
based
on
severe
Ultimately,
we
discuss
challenging
NP-codelivery
translation
provide
potential
approaches
address
limitations.
offers
comprehensive
overview
recent
cutting-edge
NP-mediated
combination
Science Advances,
Journal Year:
2023,
Volume and Issue:
9(29)
Published: July 19, 2023
The
polarization
of
tumor-associated
macrophages
(TAMs)
from
M2
to
M1
phenotype
demonstrates
great
potential
for
remodeling
the
immunosuppressive
tumor
microenvironment
(TME)
hepatocellular
carcinoma
(HCC).
d-lactate
(DL;
a
gut
microbiome
metabolite)
acts
as
an
endogenous
immunomodulatory
agent
that
enhances
Kupffer
cells
clearance
pathogens.
In
this
study,
DL
transformation
TAMs
was
confirmed,
and
mechanisms
underlying
such
were
mainly
due
modulation
phosphatidylinositol
3-kinase/protein
kinase
B
pathway.
A
poly(lactide-co-glycolide)
nanoparticle
(NP)
used
load
DL,
DL-loaded
NP
modified
with
HCC
membrane
macrophage-binding
peptide
(M2pep),
forming
nanoformulation
(DL@NP-M-M2pep).
DL@NP-M-M2pep
transformed
remodeled
TME
in
mice,
promoting
efficacy
anti-CD47
antibody
long-term
animal
survival.
These
findings
reveal
TAM
modulatory
function
provide
combinatorial
strategy
immunotherapy.
Small Methods,
Journal Year:
2023,
Volume and Issue:
7(5)
Published: Jan. 5, 2023
Immunogenic
cell
death
(ICD,
also
known
as
immunogenic
apoptosis)
of
malignant
cells
is
confirmed
to
activate
the
host
immune
system
prevent,
control,
and
eliminate
tumors.
Recently,
a
range
chemotherapeutic
drugs
have
been
repurposed
ICD
inducers
applied
for
tumor
immunotherapy.
However,
several
hurdles
widespread
application
remain,
namely
poor
water
solubility,
short
blood
circulation,
non-specific
tissue
distribution,
severe
toxicity.
Recent
advances
in
nanotechnology
pharmaceutical
formulation
foster
development
nano
drug
delivery
systems
tackle
aforementioned
expedite
safe,
effective,
specific
delivery.
This
review
will
describe
barriers
chemical
highlight
recent
nanoformulations
these
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1656 - 1656
Published: June 5, 2023
Quercetin
(QUE)
is
a
flavonol
that
has
recently
received
great
attention
from
the
research
community
due
to
its
important
pharmacological
properties.
However,
QUE's
low
solubility
and
extended
first-pass
metabolism
limit
oral
administration.
This
review
aims
present
potential
of
various
nanoformulations
in
development
QUE
dosage
forms
for
bioavailability
enhancement.
Advanced
drug
delivery
nanosystems
can
be
used
more
efficient
encapsulation,
targeting,
controlled
release
QUE.
An
overview
primary
nanosystem
categories,
formulation
processes,
characterization
techniques
are
described.
In
particular,
lipid-based
nanocarriers,
such
as
liposomes,
nanostructured-lipid
carries,
solid-lipid
nanoparticles,
widely
improve
absorption
increase
antioxidant
activity,
ensure
sustained
release.
Moreover,
polymer-based
nanocarriers
exhibit
unique
properties
improvement
Absorption,
Distribution,
Metabolism,
Excretion,
Toxicology
(ADME(T))
profile.
Namely,
micelles
hydrogels
composed
natural
or
synthetic
polymers
have
been
applied
formulations.
Furthermore,
cyclodextrin,
niosomes,
nanoemulsions
proposed
alternatives
administration
via
different
routes.
comprehensive
provides
insight
into
role
advanced
Immunological Reviews,
Journal Year:
2023,
Volume and Issue:
321(1), P. 94 - 114
Published: Aug. 7, 2023
Immunogenic
cell
death
(ICD)
is
a
unique
mode
of
death,
which
can
release
immunogenic
damage-associated
molecular
patterns
(DAMPs)
and
tumor-associated
antigens
to
trigger
long-term
protective
antitumor
immune
responses.
Thus,
amplifying
"eat
me
signal"
during
tumor
ICD
cascade
critical
for
cancer
immunotherapy.
Some
therapies
(radiotherapy,
photodynamic
therapy
(PDT),
photothermal
(PTT),
etc.)
inducers
(chemotherapeutic
agents,
have
enabled
initiate
and/or
facilitate
activate
Recently,
nanostructure-based
drug
delivery
systems
been
synthesized
inducing
through
combining
treatment
chemotherapeutic
photosensitizers
PDT,
transformation
agents
PTT,
radiosensitizers
radiotherapy,
etc.,
loaded
at
an
appropriate
dosage
in
the
designated
place
time,
contributing
higher
efficiency
lower
toxicity.
Also,
immunotherapeutic
combination
with
produce
synergetic
effects,
thus
potentiating
Overall,
our
review
outlines
emerging
inducers,
nanostructure
loading
diverse
evoke
chemoradiotherapy,
PTT
or
agents.
Moreover,
we
discuss
prospects
challenges
harnessing
induction-based
immunotherapy,
highlight
significance
multidisciplinary
interprofessional
collaboration
promote
optimal
translation
this
strategy.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(28)
Published: March 12, 2024
Abstract
Diabetes
mellitus
(DM)
is
characterized
by
elevated
blood
glucose
and
advanced
glycation
end
product
(AGEs)
levels.
Increased
AGEs
in
bone
tissue
inhibit
osteogenic
differentiation
marrow
mesenchymal
stem
cells
(BMSCs),
leading
to
loss
osteoporosis
diabetic
patients.
Enhancing
the
capacity
of
BMSCs
presence
abundant
can
improve
health
prevent
DM
The
flavonoid,
Quercetin,
has
anti‐inflammatory,
antibacterial,
antitumor
properties;
however,
it
insoluble
water
thus
not
easily
absorbed
body.
Nanodrug
delivery
systems
such
as
tetrahedral
framework
nucleic
acids
(tFNAs)
exhibit
excellent
biocompatibility,
efficient
cell
uptake,
drug
piggybacking.
In
present
study,
tFNAs
with
quercetin
complexed
form
a
novel
nanodrug
(tFNAs/Que)
that
combined
features
both
components.
tFNAs/Que
promote
an
vitro
AGEs‐rich
environment,
maintain
mass,
mice
vivo.
mechanism
against
may
be
related
JNK
signaling
pathway.
conclusion,
shown
dual
regulatory
role
promoting
inhibiting
apoptosis.
Such
feature
promising
for
prevention
treatment
osteoporosis.
MedComm – Oncology,
Journal Year:
2024,
Volume and Issue:
3(1)
Published: March 1, 2024
Abstract
Rapid
growth
in
nanoparticles
(NPs)
as
delivery
systems
holds
vast
promise
to
promote
therapeutic
approaches
for
cancer
treatment.
Presently,
a
diverse
array
of
NPs
with
unique
properties
have
been
developed
overcome
different
challenges
and
achieve
sophisticated
routes
enhancement
series
therapies.
Inspiring
advances
achieved
the
field
therapy
using
NPs.
In
this
review,
we
aim
summarize
up‐to‐date
progression
addressing
various
challenges,
expect
elicit
novel
potential
opportunities
alternatively.
We
first
introduce
sorts
NP
technologies,
illustrate
their
mechanisms,
present
applications.
Then,
achievements
made
by
break
obstacles
delivering
cargoes
specific
sites
through
particular
are
highlighted,
including
long‐circulation,
tumor
targeting,
responsive
release,
subcellular
localization.
subsequently
retrospect
recent
research
treatments
from
single
therapy,
like
chemotherapy,
combination
chemoradiotherapy,
integrative
therapy.
Finally,
perspectives
impact
on
oncology
discussed.
believe
review
can
offer
deeper
understanding
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 20, 2024
Triple
negative
breast
cancer
(TNBC)
featuring
high
relapses
and
metastasis
shows
limited
clinical
therapeutic
efficiency
with
chemotherapy
for
the
extremely
complex
tumor
microenvironment,
especially
angiogenesis
immunosuppression.
Combination
of
antiangiogenesis
immunotherapy
holds
promise
effective
inhibition
proliferation
invasion,
while
it
remains
challenging
specific
targeting
drug
delivery
to
tumors
metastatic
lesions.
Here,
a
multifunctional
biomimetic
liposome
loading
Gambogic
acid
(G/R-MLP)
is
developed
using
Ginsenoside
Rg3
(Rg3)
substitute
cholesterol
cell
membrane
coating,
which
designed
increase
long-circulating
action
by
low
immunogenicity
specifically
deliver
gambogic
(GA)
site
lesions
homologous
glucose
transporter
targeting.
After
G/R-MLP
accumulates
in
primary
nodules,
synergistically
enhances
antitumor
efficacy
GA,
effectively
suppressing
growth
lung
killing
cells,
inhibiting
migration
achieving
improving
immunity.
All
all,
strategy
combining
chemotherapy,
antiangiogenesis,
improves
prolonged
survival,
providing
new
perspective
treatment
TNBC.
Journal of Advanced Research,
Journal Year:
2024,
Volume and Issue:
66, P. 303 - 328
Published: Jan. 7, 2024
Rare
ginsenosides
(Rg3,
Rh2,
C-K,
etc.)
refer
to
a
group
of
dammarane
triterpenoids
that
exist
in
low
natural
abundance,
mostly
produced
by
deglycosylation
or
side
chain
modification
via
physicochemical
processing
metabolic
transformation
gut,
and
last
but
not
least,
exhibited
potent
biological
activity
comparing
the
primary
ginsenosides,
which
lead
high
concern
both
research
development
ginseng
ginsenoside-related
nutraceutical
products.
Nevertheless,
comprehensive
review
on
these
promising
compounds
is
available
yet.
Review
In
this
review,
recent
advances
(RGs)
were
summarized
dealing
with
structurally
diverse
characteristics,
traditional
usage,
drug
discovery
situation,
clinical
application,
pharmacological
effects
underlying
mechanisms,
structure-activity
relationship,
toxicity,
stereochemistry
properties,
production
strategies.
Key
Scientific
Concepts
A
total
144
RGs
skeletons
bioactivities
isolated
from
Panax
species.
acted
as
ligands
some
specific
receptors,
such
bile
acid
steroid
hormone
adenosine
diphosphate
(ADP)
receptors.
The
showed
including
immunoregulatory
adaptogen-like
effect,
anti-aging
anti-tumor
well
their
cardiovascular
cerebrovascular
system,
central
nervous
obesity
diabetes,
interaction
gut
microbiota.
Clinal
trials
indicated
potential
RGs,
while
quality
data
remains
inadequate,
no
obvious
was
founded.
properties
induced
at
C
(20)
also
addressed
pharmacodynamics
behaviors,
together
state-of-art
analytical
strategies
for
identification
saponin
stereoisomers.
Finally,
batch
preparation
targeted
designated
heating
acid/
alkaline-assisted
processes,
enzymatic
biotransformation
biosynthesis
discussed.
Hopefully,
present
can
provide
more
clues
extensive
understanding
future
in-depth
originated
worldwide
recognized
plants.